Thomas Rasmussen
Corporate Officer/Principal bij VectorY BV
Profiel
Thomas Gundelund Rasmussen holds an MSc in Systems Biology from the Technical University of Denmark and Stanford University.
Thomas bring extensive experience in company creation and validating new technologies within drug development (immunology, gastroenterology, women's health and CNS) as well as industrial biotechnology (synthetic biology, meat protein replacements and alternative fuels).
Having lived and worked in China, Brazil, USA and Denmark he has been involved in bringing several products to market at at biotech leaders Novozymes & Chr.
Hansen within biofuels, infant nutrition and synthetic biology, before leading the creation of the pharmaceutical division at Chr.
Hansen.
He then joined Flagship Pioneering company Kaleido Biosciences as VP of Business Development and Immuno Oncology.
At Kaleido Biosciences he lead the collaboration with Prof Laurence Zitvogel at Gustave Roussy in Paris.
Before joining Forbion as Operating Partner and VectorY as interim head of BD, he co-founded clinical stage company Freya Biosciences with Laura Ensign at Johns Hopkins University among others, to pioneer the development of immunotherapies in womens health.
Thomas is involved in several start-up incubators, including as co-founder of the dual degree M.Sc.
in Bioentrepreneurship at Copenhagen Business School.
Actieve functies van Thomas Rasmussen
Bedrijven | Functie | Begin |
---|---|---|
VectorY BV
VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Corporate Officer/Principal | 01-12-2021 |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Private Equity Investor | 01-09-2022 |
Eerdere bekende functies van Thomas Rasmussen
Bedrijven | Functie | Einde |
---|---|---|
KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01-07-2021 |
CHRISTIAN HANSEN | Corporate Officer/Principal | 01-10-2018 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 01-09-2015 |
Opleiding van Thomas Rasmussen
Stanford University | Undergraduate Degree |
Technical University of Denmark | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
KALEIDO BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
VectorY BV
VectorY BV Miscellaneous Commercial ServicesCommercial Services VectorY BV is a biotech company based in Amsterdam, Netherlands, that is dedicated to developing transformative medicines for people with neurodegenerative diseases such as ALS, Huntington's, and Parkinson's. VectorY's platform combines the promise of precise therapeutic antibodies with one-time AAV-based delivery to the CNS, enabling long-lasting CNS treatment after a single administration using cutting-edge antibody, AAV, and manufacturing technologies. The Dutch company's unique in-house expertise in antibodies, AAV vectors, protein degradation, manufacturing, and neuroscience drives the rapid development of much-needed disease-modifying therapies for neurodegenerative diseases. The company was founded by Sander J. van Deventer and Pavlina Konstantinova, with Sander J. van Deventer serving as the CEO since incorporation. | Commercial Services |
Chr. Hansen Holding A/S
Chr. Hansen Holding A/S Food: Specialty/CandyConsumer Non-Durables Chr. Hansen Holding A/S is a bioscience company engaged in the development of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. It operates through the following segments: Food Cultures & Enzymes and Health & Nutrition. The Food Cultures & Enzymes segment is focused on producing and selling the cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of consumer products in the food industry. The Health & Nutrition segment is involved in the manufacturing and distribution of products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. The company was founded by Christian Ditlev Ammentorp Hansen in 1874 and is headquartered in Horsholm, Denmark. | Consumer Non-Durables |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |